Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Neurol ; 51(6): 820-5, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25456303

ABSTRACT

BACKGROUND: Diagnostic difficulty in mitochondrial diseases (MD) results not only from the wide spectrum of symptoms and signs but also from the absence of a reliable screening or diagnostic biomarker. AIM: To investigate the likelihood of MD in patients with symptoms and signs impressive of MD through quantitative measurement of plasma amino acids, and urinary organic acids. METHODS: Twenty patients with symptoms and signs suggestive of MD were further evaluated by quantitative plasma amino acids and urinary organic acids assay and neuroimaging. RESULTS: Plasma amino acid results revealed elevation of alanine in 11, glycine in five, and proline in two patients. Abnormal urinary organic acid analysis was present in six patients; increased urinary lactate (20%), dicarboxylicaciduria (15%), and urinary ketone bodies (10%). Upon enrollment our patients scored as possible MD according to the MD scoring system. At the end of the study, five patients still scored as possible MD, eight patients as probable MD, and seven patients as definite MD. All patients with definite MD had elevated serum lactate. In three patients, elevated urinary lactate was the only abnormality. Alanine was elevated in all patients with definite MD, whereas proline was elevated in only one. Magnetic resonance imaging of the brain showed atrophic changes in one patient and bilateral basal ganglia hyperintensity in another. CONCLUSION: Urinary organic acids and quantitative plasma amino acids can help in the diagnosis of MD, especially when the economic burden and absence of specialized centers limits the diagnosis.


Subject(s)
Amino Acids/blood , Biomarkers , Carboxylic Acids/urine , Mitochondrial Diseases/diagnosis , Biomarkers/blood , Biomarkers/urine , Child , Child, Preschool , Female , Humans , Infant , Male , Mitochondrial Diseases/blood , Mitochondrial Diseases/urine
2.
Pediatr Neurol ; 47(2): 114-8, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22759687

ABSTRACT

Pediatric stroke is relatively uncommon, with often subtle clinical presentations. Numerous predisposing risk factors can be both inherited and acquired, including cardiac disease, vascular abnormalities, infectious diseases, collagen tissue diseases, inborn errors of metabolism, anticardiolipin antibody, lupus anticoagulant, deficiencies of protein C, protein S, antithrombin, or plasminogen, and prothrombotic mutations. We explored risk factors, clinical features, and neuroimaging among Egyptian children with ischemic stroke, and estimated the prevalence of inherited thrombophilia. We included 20 children with ischemic stroke, recruited from the Pediatric Neurology Outpatient Clinic (Ain Shams University). Basic clinical evaluations for stroke and genotyping for factor V 1691 G-A (factor V Leiden), prothrombin 20210 G-A mutations, and methylenetetrahydrofolate reductase 677 C-T polymorphisms were performed using real-time polymerase chain reaction, with fluorescent melting curve detection analysis. Ten patients (50%) manifested methylenetetrahydrofolate reductase polymorphisms (six homozygotes and four heterozygotes). Heterozygous factor V Leiden was present in five (25%), whereas prothrombin mutation was present in only one (5%). Five patients (25%) manifested combined prothrombotic abnormalities. Thirteen demonstrated evidence of inherited thrombophilic disorder; 25% manifested more than one mutation. For appropriate risk assessment, even in the presence of overt acquired thrombotic risk factors, physicians should request complete thrombophilia screening for patients with stroke.


Subject(s)
Brain Ischemia/epidemiology , Stroke/epidemiology , Thrombophilia/epidemiology , Thrombophilia/genetics , Adolescent , Brain Ischemia/diagnosis , Brain Ischemia/genetics , Child , Child, Preschool , Egypt/epidemiology , Female , Humans , Infant , Infant, Newborn , Male , Prospective Studies , Stroke/diagnosis , Stroke/genetics , Thrombophilia/diagnosis
3.
J Egypt Soc Parasitol ; 34(2): 621-30, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15287184

ABSTRACT

Thirty six patients presenting with gastrointestinal symptoms were studied for the presence of specific anti-Giardia lamblia salivary IgA antibodies. Stool samples were examined for parasites especially G. lamblia by direct smear. Duodenal aspirate was examined for the parasite. Saliva samples were collected from each patient and examined by ELISA technique for the specific anti-Giardia lamblia IgA antibodies. 94.4% of positive cases for G. laimblia by stool analysis had positive anti-Giardia salivary IgA antibodies. 33.3% of stool negative cases were positive for anti-Giardia salivary IgA antibodies. All Giardia negative cases by duodenal aspirate examination were negative for anti-Giardia salivary IgA antibodies. Detection of antiGiardia salivary IgA antibodies was an excellent tool for screening G. lamblia in patients with long standing symptoms of more than one month duration.


Subject(s)
Antibodies, Protozoan/isolation & purification , Gastrointestinal Diseases/parasitology , Giardia lamblia/immunology , Giardiasis/diagnosis , Immunoglobulin A/isolation & purification , Saliva/parasitology , Animals , Antigens, Protozoan , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay/methods , Feces/parasitology , Gastrointestinal Diseases/diagnosis , Giardiasis/parasitology , Humans , Saliva/immunology
4.
Epilepsia ; 44(3): 447-52, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12614402

ABSTRACT

PURPOSE: This study was designed to investigate the effect of epilepsy and antiepileptic drugs (AEDs) on both the physical and hormonal aspects of the sexual development of male patients with epilepsy. METHODS: One hundred thirty male subjects with epilepsy, their age ranging between 8 and 18 years (mean, 14 +/- 2.9 years), entered the study; all were taking AEDs. Anthropometric measurements [height, weight, and body mass index (BMI)], testicular volume, penile length, and pubarche were assessed in the studied groups, as well as measurement of the levels of testosterone (T), free testosterone (FT), estradiol (E2), lutenizing hormone (LH), follicle-stimulating hormone (FSH), and prolactin (PRL), and the results were compared with those of a control group. RESULTS: In this study, male patients older than 16 years were significantly shorter than their matched controls. The mean values of testicular volume and penile length were significantly lower in the patients in the different age subgroups, and the pubic hair staging (pubarche) was delayed in the patients older than 16 years. The mean values of total testosterone, estradiol, LH, and FSH serum levels were significantly higher, whereas the mean values of free testosterone, total-T/E2, total. T/LH, and FT/E2 ratios were lower in the patient subgroups compared with their age-matched controls. There were no significant changes in the mean basal PRL serum levels in the patients compared with the controls. The present study demonstrated a reduction in the testicular volume and penile length, significantly lower mean values of free testosterone and total-T/E2, and a higher mean value of E2 in the patients receiving polytherapy in the age subgroup older than 16 years compared with those on monotherapy; however, there was no demonstrable effect of seizure control or the duration of illness in any of the studied parameters. CONCLUSIONS: There is a delay in the sexual development of male patients with epilepsy in the different age subgroups, with endocrine changes in the form of increase in the total testosterone, but the free testosterone is lower, and an increase in estradiol, with lower T/LH levels. Patients receiving polytherapy, especially those older than 16 years, were more likely to have delayed gonadarch and disturbances in their hormonal profile.


Subject(s)
Epilepsy/diagnosis , Gonadal Steroid Hormones/blood , Sexual Maturation/physiology , Adolescent , Anthropometry , Anticonvulsants/adverse effects , Anticonvulsants/pharmacology , Anticonvulsants/therapeutic use , Child , Epilepsy/blood , Epilepsy/drug therapy , Estradiol/blood , Follicle Stimulating Hormone/blood , Humans , Luteinizing Hormone/blood , Male , Penis/drug effects , Penis/growth & development , Prolactin/blood , Puberty/drug effects , Puberty/physiology , Sex Characteristics , Sex Factors , Sexual Maturation/drug effects , Testis/drug effects , Testis/growth & development , Testosterone/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...